AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05673330 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial Release Technique
Description: Suboccipital Inhibition Technique: While the patient will be in the supine position, the physician sitting at the top end of the table will place the fingers of both hands on the patient's suboccipital region. Flexi-perpendicular long fingers exerting an inhibitory pressure on the muscle insertions of the neck extensors in the occiput, perpendicularly to muscle fibers, while the thumbs counterbalance the head against rotation. A deep and progressive pressure would be applied perpendicular to the fibers until a decrease in muscle tone would be detected. This deep and progressive pressure would be maintained for a total of 10 min until release of suboccipital tissues is achieved.~The patients will receive myofascial release with the frequency of 1 set and 10 repetitions once a day three times per week for four weeks. Pre and post intervention values will be taken on 1st day and after 4 weeks.
Study NCT06490237 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode
Description: During surgery using a retro-sigmoid approach in the cerebellopontine angle (microvascular decompression, vestibular neurotomy, meningioma or schwannoma removal), near-field recording of human auditory nerve activity using a contact electrode is performed on patients with normal or impaired hearing threshold.~Each patient is explored preoperatively by hearing tests in noise and in silence. During the operation, stimuli are delivered in silence and in noise, under the same conditions as during the preoperative auditory exploration.
Study NCT06490237 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode
Description: During surgery using a retro-sigmoid approach in the cerebellopontine angle (microvascular decompression, vestibular neurotomy, meningioma or schwannoma removal), near-field recording of human auditory nerve activity using a contact electrode is performed on patients with normal or impaired hearing threshold.~Each patient is explored preoperatively by hearing tests in noise and in silence. During the operation, stimuli are delivered in silence and in noise, under the same conditions as during the preoperative auditory exploration.
Study NCT04793048 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: a noninvasive intraoral electrotherapy device
Description: a noninvasive intraoral electrotherapy device to treat periodontal disease at-home for 20 minutes a day
Study NCT04793048 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: a sham device
Description: a sham device to be used at-home for 20 minutes a day
Study NCT05569603 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Chronobiology-guided lifestyle interventions
Description: 1) timed bright light exposure using blue-enriched white light glasses, 2) recommendations for meal timing, and 3) sleep hygiene education
Study NCT06319937 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Ultrasound
Study NCT05472662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo 152a
Description: Placebo pressurised metered-dose inhaler (pMDI) formulated with the 152a propellant
Study NCT05472662 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 134a
Description: Placebo pressurised metered-dose inhaler (pMDI) formulated with the 134a propellant
Study NCT06432049 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: restoration for endodontically treated molar
Description: prefabricated stainless steel crown or endocrown
Study NCT04842773 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound measurement
Description: Ultrasound measurement of sarcopenia in an elderly population
Study NCT05275088 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prizvalve® system
Description: Transcatheter atrioventricular valve replacement
Study NCT05297136 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pancreatic Stenting
Description: Pancreatic stent of appropriate size and length is inserted to the pancreatic duct before distal pancreatectomy
Study NCT05297136 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No Stent
Description: No preoperative stenting with distal pancreatectomy alone
Study NCT05103241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C] GP681
Description: 40 mg suspension containing 100μCi of \[14C\]GP681
Study NCT05080426 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Supportive Supervisor Training 2.0
Description: FSST 2.0 is a workplace intervention package designed to increase supervisors' family and leave supportive behaviors and leave supportive behaviors. The package includes Workplace Assessment tool, 2 45-60 minute online training modules (family-supportive supervisor training and supervisors' leave supportive behavior training), a webinar, behavior training, and individualized feedback reports.
Study NCT03435718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxfendazole
Description: oral suspension
Study NCT03435718 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albendazole
Description: tablet
Study NCT06262282 — intervention group
Intervention type: BIOLOGICAL
Intervention: mycobacteriophage
Description: mycobacteriophage phage that has been found effective in killing participants NTM infection
Study NCT05100784 — intervention group
Intervention type: BIOLOGICAL
Intervention: HSSA test
Description: Human Sperm Survival Assay testing performed on different batches of different types of IVF consumables. In practice, 3 consumables from the same batch will be tested with 3 different sperms to ensure the repeatability of the result / test.
Study NCT05007587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: 8mg lenvatinib (weight\<60kg) or 12mg lenvatinib (weight>60kg) QD
Study NCT05253755 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DBI-001
Description: Topical application of DBI-001 gel on skin affected with atopic dermatitis.
Study NCT05253755 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Aqueous gel
Description: Topical application of aqueous gel on skin affected with atopic dermatitis.
Study NCT02523092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acthar gel
Description: Acthar gel given IM or SQ as per package insert
Study NCT05007587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX regimen
Description: HAIC was performed every 3 weeks. The mFOLFOX regimen was administered via hepatic artery: oxaliplatin , 85mg/m2 , from hour 0 to 2 on day1 ; leucovorin , 400mg/m2 , from hour 2 to 3 on day 1 ; fluorouracil , 400mg/m2 , bolus at hour 3 ; and 2400mg/m2 over 46 hours on days 1 and 2.3mg/m2 , from hour 4 to 5 on day 1.
Study NCT05007587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ROX regimen
Description: HAIC was performed every 3 weeks. The ROX regimen was administered via hepatic artery: oxaliplatin , 100mg/m2 , from hour 0 to 4 on day1 ;raltitrexed , 3mg/m2 , from hour 4 to 5 on day 1.
Study NCT04716478 — intervention group
Intervention type: OTHER
Intervention: Clinical and radiological data collection
Description: No specific intervention. Data of the usual care will be collected as the demographic data, the medical history, imaging report, etc.
Study NCT05946707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: restrictive oxygen supply
Description: Oxygen supply will be limited to guarantee normoxia at the beginning of OLV.
Study NCT05946707 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: liberal oxygen supply
Description: Oxygen supply will be maximized to 100% at the beginning of OLV
Study NCT05444413 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ultrasound-guided platelet rich plasma nerve block
Description: selected persons are treated by ultrasound-guided platelet rich plasma nerve block and the regular medicine
Study NCT05110599 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bryophyllum 50% chewable tablets
Description: Each 350 mg tablet corresponds to 170 mg of leave press juice from Bryophyllum pinnatum, dried down to 17 mg by mixing with lactose; 100 mg dried BP matter in 1 g
Study NCT05110599 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Lactose with adaption in appearance and tast
Study NCT05718661 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Watching video with virtual glasses
Description: Using Mobile Virtual Glasses; In the preoperative period, after the patient is taken to the surgical service, a virtual reality video will be watched with mobile virtual glasses at the specified time (before going to the operating room on the day of surgery). Measurements will be made before and after the application. Necessary hygiene will be provided before the use of glasses, and the researcher will ensure hand cleaning before entering the patient's room.
Study NCT05718661 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: watching video without virtual glasses
Description: The plain version of the video, which was shown to the intervention group by the researcher (SŞ) to the placebo group, will be watched over the phone with the naked eye and the stress level on the smart bracelet will be recorded.
Study NCT05340491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: 240mg, D1, every 3 weeks per cycle, three cycles with chemotherapy and eight cycles after IMRT
Study NCT05340491 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: Gemcitabine: 1.0g/m2, D1 and D8, Cisplatin 80mg/m2, D1, every 3 weeks per cycle, total three cycles
Study NCT05340491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Gemcitabine: 1.0g/m2, D1 and D8, Cisplatin 80mg/m2, D1, every 3 weeks per cycle, total three cycles
Study NCT05340491 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity modulated radiotherapy
Description: total 60-66Gy, 1.8-2.0Gy/f/day
Study NCT05340491 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity modulated radiotherapy
Description: total 60-66Gy, 1.8-2.0Gy/f/day
Study NCT06075862 — intervention group
Intervention type: PROCEDURE
Intervention: Decompressive surgery
Description: Decompressive lumbar spinal surgery
Study NCT04896541 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD7442 300 mg IM(male)
Description: Single dose of 300 mg of AZD7442 or saline placebo on Day 1.
Study NCT04896541 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD7442 600 mg IM (male)
Description: Single dose of 600 mg of AZD7442 or saline placebo on Day 1.
Study NCT06231875 — intervention group
Intervention type: DEVICE
Intervention: Press
Description: Fabrication of clear aligners using press machine (Mini-star)
Study NCT04896541 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD7442 300 mg IV (male and female)
Description: Single dose of 300 mg of AZD7442 or saline placebo on Day 1.
Study NCT04896541 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD7442 1000 mg IV (male)
Description: Single dose 1000 mg of AZD7442 or saline placebo on Day 1.
Study NCT04303104 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: GeneXpert Edge
Description: Screening intervention: novel diagnostic for Active Case Finding (GeneXpert MTB/RIF) for TB on sputum collected and performed at point-of-contact in a mobile van
Study NCT04303104 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: GeneXpert Ultra
Description: Screening intervention: novel diagnostic test for Active Case Finding (GeneXpert MTB/RIF) for TB on sputum collected at point-of-contact in a mobile van but sent to laboratory
Study NCT05332665 — intervention group
Intervention type: DEVICE
Intervention: AS-OCT
Description: Anterior segment optical coherence tomography (AS OCT) is an imaging device that can acquire an anterior segment image using a noncontact method with the patient in a sitting position. This device provides reproducible and quantitative measurements of the AC angle and other anterior segment parameters.
Study NCT05332665 — intervention group
Intervention type: PROCEDURE
Intervention: YAG laser PI
Description: medical procedure which uses a laser device to create a hole in the iris, thereby allowing aqueous humor to traverse directly from the posterior to the anterior chamber and, consequently, relieve a pupillary block
Study NCT05054920 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: concentric exercises
Description: concentric exercises for rotator cuff. internal rotators, external rotators and abductors Patient will do 3 sets of 10 repetitions resistance will be personalized to each patients
Study NCT05054920 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eccentric exercises
Description: Eccentric exercises exercises for rotator cuff internal rotators, external rotators and abductors Patient will do 3 sets of 10 repetitions resistance will be personalized to each patients
Study NCT05054920 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching
Description: stretching exercise for posterior capsule and pectoralis minor each stretch will be done for 30 seconds and repeated 3 times
Study NCT04863677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training(HIIT）
Description: Last 12 weeks (3 sessions per week)
Study NCT04863677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training(MICT）
Description: Moderate Intensity Continuous Training(MICT）
Study NCT05477316 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation treatment
Description: Radiation treatment of IMRT to the cerebellum and SRS to the cerebrum
Study NCT05625646 — intervention group
Intervention type: OTHER
Intervention: quality assurance program
Description: The program consists of an online quiz using a multiple choice questionnaire (MCQ) design. The participants are expected to complete the online MCQ at 3, 6, 9, and 12 months following baseline. The MCQ includes still-pictures and video sequences of the 10 application specific POCUS examinations from the course curriculum. Through 15-20 questions, the quiz tests the OSAUS dimentions Each question has four possible answers of which up to three answers are correct. Each MCQ will have ten questions pertaining to pathologies within the ten applications of the curriculum. Further, there will be five to ten questions relating to image recognition, image optimisation, ultrasound artifacts. Once each MCQ is finalized, the participating GP's will receive feed-back on the answers with suggestions for improvement and guidance toward continuing self-directed learning.
Study NCT04511988 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diagnostic Test
Description: blood sample (20 ml) and biopsy
Study NCT05865301 — intervention group
Intervention type: OTHER
Intervention: Questionnaire for patients receiving therapy
Description: Questionnaires will be given (at baseline, 1, 3, 6, and 12 months post CAR infusion) including baseline demographics, individual/family and neighborhood socioeconomic data, measures of household material hardship (housing and transportation insecurity, household energy and food insecurity), barriers to care at the CAR T cell institution, as well as patient reported outcomes following Kymriah infusion.
Study NCT05711706 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Su Jok Application
Description: Su Jok massage appplication
Study NCT06442904 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital education program
Description: The approximately six hours long digital education program will be available for three months and implies further education in intraoral radiographic examinations.
Study NCT05318300 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: tested formula with fiber
Description: formula containing fibers
Study NCT05318300 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: formula without fiber
Study NCT05354492 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Program to Support Well-Being after Adversity
Description: You will be asked to meet on Zoom weekly for 6 weeks with our trained program facilitators along with the other 6-10 members of the intervention group. Meetings will last approximately 75-90 minutes each, and will involve a variety of discussions and activities related to navigating the changes you may face after experiencing a difficult life event. These sessions will be audio-recorded for research purposes and to ensure that facilitators are doing a good job delivering the program.
Study NCT05674227 — intervention group
Intervention type: PROCEDURE
Intervention: Robotic surgery
Description: Surgical treatment of operable lung cancers using robotic systems
Study NCT05674227 — intervention group
Intervention type: PROCEDURE
Intervention: Video-assisted thoracoscopy
Description: Surgical treatment of operable lung cancers using a video-assisted thoracoscopy approach (VAT)
Study NCT05674227 — intervention group
Intervention type: PROCEDURE
Intervention: Open surgery
Description: Surgical treatment of operable lung cancers using open surgery
Study NCT06291311 — intervention group
Intervention type: OTHER
Intervention: Cold physical Plasma
Description: The treatment is administered by either the supervising specialists or assistant doctors at the University Women's Hospital, under their supervision and authorization. It's important to note that the NIPP treatment is designed to be relatively brief, with a duration not exceeding 10-20 minutes.
Study NCT06291311 — intervention group
Intervention type: OTHER
Intervention: Control group
Description: A potential natural healing of the HPV infection will be anticipated
Study NCT05646225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chest physiotherapy and early mobilization
Description: Chest Physiotherapy: Each session included a series of exercises, lasting a total of 15 minutes and including positioning self-conscious breathing control, diaphragmatic breathing control, and exercises for the chest wall and abdominal muscle walls.~Early mobilization: Each session included abdominal and upper and lower limb exercises, shoulder and full arm circling, lying to sit, sit to stand, walk and other exercises. This training has been described previously and used in other clinical trials. Each exercise was repeated 8-10 times over 30 minutes
Study NCT05646225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: early mobilization
Description: Each session included abdominal and upper and lower limb exercises, shoulder and full arm circling, lying to sit, sit to stand, walk and other exercises. This training has been described previously and used in other clinical trials. Each exercise was repeated 8-10 times over 30 minutes
Study NCT05646225 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: early mobilization
Description: Each session included abdominal and upper and lower limb exercises, shoulder and full arm circling, lying to sit, sit to stand, walk and other exercises. This training has been described previously and used in other clinical trials. Each exercise was repeated 8-10 times over 30 minutes
Study NCT05448729 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Elastography EUS
Description: Comparison between the values of strain ratio and shear wave in concordance with the final diagnosis
Study NCT05448729 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Elastography EUS
Description: Comparison between the values of strain ratio and shear wave in concordance with the final diagnosis
Study NCT05400850 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: YOGA
Description: Five different YOGA Asana's will made randomly
Study NCT06374004 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Group
Description: The exercises will be given as a home program and each exercise will be performed 2 times a day for a total of 12 weeks. Participants will perform the exercises 1 day a week under the supervision of a physiotherapist. The exercise program lasts approximately 30 minutes.
Study NCT06374004 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Mobilization Group
Description: The exercises will be given as a home program and each exercise will be performed 2 times a day for a total of 12 weeks. Participants will perform the exercises 1 day a week under the supervision of a physiotherapist. The exercise program lasts approximately 30 minutes. Thoracic mobilization will be applied to segments where passive accessory movement is insufficient or painful. 30 repetitions/4 sets will be applied to each determined segment. Thoracic mobilization will be performed with the patient lying prone position.
Study NCT05535764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha2a
Description: PegINFa will be given once every 2 weeks by subcutaneous administration in the abdomen or thigh.
Study NCT05235100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib Mesylate
Description: Apatinib Mesylate 500mg QD, begin from 2 weeks prior to IMRT, to 1 month after end of IMRT